Individually or in combination, the elevation in lymphoblasts of mitochondrial respiration, ATP levels, and AMPK activity, as well as the reduction in ROS levels and TORC1 activity could potentially provide biomarkers of FXTAS or its progression. Here, PRKAA1 is linked to fragile X-associated tremor/ataxia syndrome.